Product Safety Recalls

Product Recall Tracker

TRETINOIN Recall D-1156-2022

Description: Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC 0555-0808-02.

TRETINOIN Recall D-1156-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1156-2022
Event ID90430
BrandTRETINOIN
Generic NameTRETINOIN
ManufacturerTRETINOIN
Original Package?1
Active SubstanceTRETINOIN
Drug RouteORAL
DistributionNationwide in the U.S.
Quantity4941 bottles
Recall ReasonFailed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.
Drug ClassificationClass II
Drug Code Info20220629
Product NDC0555-0808
Product NUIN0000175607 M0018962
Drug UPC0305550808022
Pharma Class (EPC)Retinoid [EPC]
Pharma Class (CS)Retinoids [CS]
Recall Initiation Date20220614
Report Date20220629
Classification Date20220623
Address400 Interpace Pkwy Bldg A
Parsippany, NJ 07054-1120
United States
Recalling FirmTeva Pharmaceuticals USA Inc
Initial Notification Letter
Unique Ingredient Identifier5688UTC01R
Drug Application NumberANDA077684
Structured Product Labeling (SPL ID)4d40143c-dd75-4305-b00e-737e41e5431a
Structured Product Labeling (SPL Set ID)0f81f505-a962-414e-8612-c3ef3b159e9a
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.